Items where Author is "Gluz, Oleg"

Article

Gluz, Oleg and Wild, Peter and Liedtke, Cornelia and Kates, Ronald and Mendrik, Heiko and Ehm, Elisabeth and Artinger, Verena and Diallo-Danebrock, Raihanatou and Ting, Evelyn and Mohrmann, Svjetlana and Poremba, Christopher and Harbeck, Nadia and Nitz, Ulrike and Hartmann, Arndt and Gaumann, Andreas (2011) Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial. BREAST CANCER RESEARCH AND TREATMENT, 126 (3). pp. 643-651. ISSN 0167-6806, 1573-7217

Gluz, Oleg and Wild, Peter and Meiler, Robert and Diallo-Danebrock, Raihana and Ting, Evelyn and Mohrmann, Svjetlana and Schuett, Gerhart and Dahl, Edgar and Fuchs, Thomas and Herr, Alexander and Gaumann, Andreas and Frick, Markus and Porernba, Christopher and Nitz, Ulrike Anneliese and Hartmann, Arndt (2008) Nuclear karyopherin alpha 2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity. INTERNATIONAL JOURNAL OF CANCER, 123 (6). pp. 1433-1438. ISSN 0020-7136

Diallo-Danebrock, Raihanatou and Ting, Evelyn and Gluz, Oleg and Herr, Alexander and Mohrmann, Svjetlana and Geddert, Helene and Rody, Achim and Schaefer, Karl-Ludwig and Baldus, Stephan E. and Hartmann, Arndt and Wild, Peter J. and Burson, Michael and Gabbert, Helmut E. and Nitz, Ulrike and Poremba, Christopher (2007) Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy. CLINICAL CANCER RESEARCH, 13 (2). pp. 488-497. ISSN 1078-0432

Other

Gluz, Oleg and Liedtke, Cornelia and Saint Paul, Helene P. Peyro and Nitz, Ulrike and Kates, Ronald E. and Huober, Jans Bodo and Hartmann, Arndt and Kreipe, Hans Heinrich and Pelz, Enrico and Erber, Ramona and Kuhn, Walther and Harbeck, Nadia (2013) The prognostic and predictive impact of genomic grade index (GGI) versus central grade or molecular class in intermediate-risk breast cancer (RC); Results from the EC-Doc trial. AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA.